Evidence map›Paper›PMID 42022929›Full record

ArticleJournal of pharmaceutical analysis2026

Hyaluronic acid-modified polymeric nanoplatform delivering

Han Bao, Ning Wang, Xiaowen Zhu, Song Chen, Yang Wang, Xiangjun Han, Hongshan Zhong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Han BaoDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang, 110001, China.
Ning WangDepartment of Radiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Xiaowen ZhuDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang, 110001, China.
Song ChenDepartment of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, 110001, China.
Yang WangDepartment of Chemistry, School of Forensic Medicine, China Medical University, Shenyang, 110122, China.
Xiangjun HanDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang, 110001, China.
Hongshan ZhongDepartment of Interventional Radiology, The First Hospital of China Medical University, Shenyang, 110001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite serving as a radical alternative to surgery for inoperable colorectal hepatic metastases patients, thermal ablation faces local tumor progression rates up to 25% from residual tumors, seriously compromising treatment efficacy and survival of patients. We constructed hyaluronic acid (HA)-modified nanoparticles as carriers for the hydrophobic necrosis-avid agent

Indexed as

AblationColorectal carcinomaHyaluronic acidHypericinNanoparticleNecrosis

Identifiers

PMID42022929
PMCPMC13098511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.